We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Immunotherapy in Breast Cancer

    Breast cancer affects 12% of women worldwide. Although advances in systemic, surgical, and radiation therapy approaches will cure a large proportion...
    Jenna Hoppenworth, Roberto A. Leon-Ferre in The Basics of Cancer Immunotherapy
    Chapter 2024
  2. Breast Cancer

    Breast cancer is currently the most diagnosed cancer in the female population, with a prevalence of 1 in 8 women.
    Emilia Marrazzo, Chiara Annunziata Pasqualina Anghelone, Elena Vittoria Longhi in Managing Psychosexual Consequences in Chronic Diseases
    Chapter 2023
  3. Biosimilars in Breast Cancer

    Breast cancer is a significant health concern globally, leading to maximum mortalities amongst women worldwide, which is 11.6% of all cancers...
    Chapter 2024
  4. Breast Cancer

    Breast cancers are a major cause of mortality in females, on a par with lung and colon cancers. One topic in this chapter are the causes of breast...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  5. Resistance to Immunotherapy in Breast Cancer

    Breast cancer is the most common and second most deadly disease in women worldwide, with breast cancer screening resulting in a steady decline in...
    Botle Precious Damane, Lorraine Tshegofatso Maebele, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  6. Resistance to Endocrine Therapy in Breast Cancer

    The foremost cause of female deaths is due to breast cancer. The most frequent type of breast cancer is hormone-dependent breast cancer, being either...
    Demetra Demetriou, Richard Khanyile, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  7. Immunotherapy for Breast Cancer

    Breast cancer is one of the leading causes of mortality among women worldwide. Approximately 95% of breast malignancies are adenocarcinomas....
    Kammila Martins Nicolau Costa, Demis Ferreira de Melo, ... JoĆ£o Augusto Oshiro-JĆŗnior in Handbook of Cancer and Immunology
    Living reference work entry 2023
  8. Resistance to Targeted Therapy in Breast Cancer

    The discoveries of breast cancer molecular subtypes and their deregulated pathways have given rise to the emergence of potential therapeutic targets...
    Meshack Bida, Benny Mosoane, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  9. Mechanisms of Drug Resistance in Breast Cancer

    The incidence of breast cancer has increased over the past decades making it the most common cancer in females worldwide. Multidrug resistance (MDR)...
    McCabe Michelle, Dineo Disenyane, ... Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
  10. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features

    Background

    The tumor microenvironment clearly influences cancer progressing properties but less is known about how individual cancer microenvironments...

    Maria Carmen Leiva, Anna Gustafsson, ... Gƶran Landberg in Journal of Translational Medicine
    Article Open access 20 December 2023
  11. CTCs in Early Breast Cancer

    In the last decades, treatment options for breast cancer patients improved rapidly, leading to a more personalized treatment approach. At the moment,...
    Tatjana Braun, Angelina Fink, ... Brigitte Rack in Circulating Tumor Cells
    Chapter 2023
  12. Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution

    Background

    A reliable preclinical model of patient-derived organoids (PDOs) was developed in a case study of a 69-year-old woman diagnosed with breast...

    Serena Mazzucchelli, Lorena Signati, ... Fabio Corsi in Cancer Cell International
    Article Open access 27 June 2024
  13. Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery

    Objective

    To investigate how the negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cell lines and prognosis in...

    Fang **n Jian, Peng **ao Bao, ... Hang Guan Hong in BMC Cancer
    Article Open access 24 March 2023
  14. Role of Endorphins in Breast Cancer Pathogenesis and Recovery

    Understanding the relationship between stress and breast cancer development is essential to preventing and alleviating the cancer. Recent research...
    David H. Nguyen in Endogenous Opioids
    Chapter 2024
  15. Animal Models in Cancer Research: Breast Cancer

    This chapter covers the main animal models employed in basic research to study breast cancer, including murine (chemically induced, transplanted,...
    JanaĆ­na Carla da Silva, Aedra Carla Bufalo Kawassaki, ... Carolina Panis in Handbook of Animal Models and its Uses in Cancer Research
    Reference work entry 2023
  16. Factors associated with engraftment success of patient-derived xenografts of breast cancer

    Background

    Patient-derived xenograft (PDX) models serve as a valuable tool for the preclinical evaluation of novel therapies. They closely replicate...

    Jongwon Lee, GunHee Lee, ... Hee ** Lee in Breast Cancer Research
    Article Open access 21 March 2024
  17. Breast Cancer Therapy and Control

    We discuss breast cancer therapy using drugs in this chapter. Genetic mutations are usually irreversible and they cannot be altered by giving drugs...
    Madhumita Roy, Jaydip Biswas, Amitava Datta in Genetics and Epigenetics of Breast Cancer
    Chapter 2023
  18. Obesity and breast cancer prognosis: pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics

    Purpose

    Examine the association between obesity and clinical outcomes in early breast cancer and assess if patient, tumor, and treatment...

    Sixten Harborg, Maria Feldt, ... Signe Borgquist in Cancer & Metabolism
    Article Open access 27 June 2023
  19. Genomic Landscape of Breast Cancer

    Understanding the genomic landscape of breast cancer is a very active and rapidly evolving research area. Genome wide searches have been conducted by...
    Madhumita Roy, Jaydip Biswas, Amitava Datta in Genetics and Epigenetics of Breast Cancer
    Chapter 2023
  20. Molecular Profiling and Personalized Medicine in Drug-Resistant Breast Cancer

    The utilization of molecular profiling techniques and personalized medicine approaches in the management of breast cancer is driven by molecular...
    Lloyd Mabonga, Aristotelis Chatziioannou, Zodwa Dlamini in Overcoming Breast Cancer Therapy Resistance
    Chapter 2024
Did you find what you were looking for? Share feedback.